---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-269650"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2026-06-12T21:01:14+00:00"
generated_at: "2026-06-12T21:02:25.491750+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Apogee shareholders elect directors, ratify auditor, approve say-on-pay at 2026 annual meeting

## Summary
- Director nominees Mark C. McKenna, Jennifer Fox, William Jones elected with >44.9M votes each, broker non-votes 1.8M.
- Ratification of Ernst & Young as independent auditor for FY2026: 56.96M for, 1,361 against.
- Non-binding advisory vote on named executive officer compensation: 54.32M for, 634k against, 247k abstentions.
- All three proposals passed; no material changes to board composition or corporate governance.

## SEC filing metadata
- accession: 0001193125-26-269650
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2026-06-12T21:01:14+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/apge-20260609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-269650
- JSON: https://secwatch.observer/filing/0001193125-26-269650.json
- Plain text: https://secwatch.observer/filing/0001193125-26-269650.txt

## Key facts
- Shareholder Votes
  Apogee Therapeutics, Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-09 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: The compensation of our named executive officers as disclosed in the Proxy Statement was approved on a non-binding, advisory basis as follows: Votes For Votes Against Abstentions Broker Non-Votes 54,324,725 633,959 246,567 1,795,532
  evidence_url: https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm
- Shareholder Votes
  Apogee Therapeutics, Inc. shareholders approved Election of Class III directors at the 2026-06-09 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: The following Class III director nominees were elected to serve until the 2029 Annual Meeting of Stockholders based upon the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Mark C. McKenna 53,689,547 1,515,704 1,795,532 Jennifer Fox 52,895,552 2,309,699 1,795,532 William (BJ) Jones, Jr. 44,964,804 10,240,447 1,795,532
  evidence_url: https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm
- Shareholder Votes
  Apogee Therapeutics, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-06-09 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-09
  source text: The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified as follows: Votes For Votes Against Abstentions 56,960,778 1,361 38,644
  evidence_url: https://www.sec.gov/Archives/edgar/data/1974640/000119312526269650/0001193125-26-269650-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.